Clinical Trial

Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors

Name: Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors — clinical trial record (NCT07088588)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This interventional study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of SYN608 as monotherapy in adult patients with advanced solid tumors

Trial Details

NCT Number	NCT07088588
Lead Sponsor	Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Conditions	Advanced Solid Cancer, Metastatic Solid Tumor, Ovarian Cancer, Breast Cancer, BRCA Mutation, HRR Deficiency
Enrollment	105 participants
Start Date	2025-07-31
Primary Completion	2028-07-31 (estimated)
Study Completion	2028-10-31 (estimated)
Updated on ClinicalTrials.gov	2025-07-28